KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,697,688 | +92336.6% | 58,895 | 0.0% | 2.64% | -16.6% |
Q4 2022 | $11,573 | -99.9% | 58,895 | 0.0% | 3.17% | -17.7% |
Q3 2022 | $13,247,000 | -39.4% | 58,895 | -65.9% | 3.85% | -35.9% |
Q2 2022 | $21,873,000 | -35.6% | 172,895 | -35.5% | 6.01% | -15.4% |
Q1 2022 | $33,966,000 | -3.2% | 267,895 | 0.0% | 7.10% | +36.4% |
Q4 2021 | $35,094,000 | +7.1% | 267,895 | 0.0% | 5.20% | +5.3% |
Q3 2021 | $32,772,000 | – | 267,895 | – | 4.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |